Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|June 15, 2007
IGF-II promoter methylation and ovarian cancer prognosisA C Beeghly, D Katsaros, A L Wiley, et al.
Gynecologic Oncology|April 1, 2008
The incidence and risk factors associated with postoperative delirium in geriatric patients undergoing surgery for suspected gynecologic malignanciesJ N McAlpine, E J Hodgson, S Abramowitz, et al.
European Journal of Gynaecological Oncology|May 14, 2016
Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcomaM M Abu-Khalaf, M A Raza, C Hatzis, et al.
British Journal of Cancer|April 26, 2012
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapyS Bellone, D Roque, E Cocco, et al.
British Journal of Cancer|September 15, 2011
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumabP Todeschini, E Cocco, S Bellone, et al.
British Journal of Cancer|October 1, 2014
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivoC L Schwab, S Bellone, D P English, et al.
British Journal of Cancer|August 12, 2010
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinomaE Cocco, Z Hu, C E Richter, et al.
British Journal of Cancer|November 19, 2009
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinomaK El-Sahwi, S Bellone, E Cocco, et al.
British Journal of Cancer|June 19, 2009
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancerE Cocco, S Bellone, K El-Sahwi, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapyB C Turner, J P Knisely, B M Kacinski, et al.
Pageof 5